April 11, 2019
In 2017, The genetic team at the largest pediatric hospital in Europe, Prof Antonio Novelli and his team of geneticists used to analyze dozens of rare genetic disorder cases per month.
Since the hospital adopted the Geneyx Analysis platform they are analyzing hundreds of cases each month, with the same team. Last month Dr. Novelli reported turn-around-time of 1-10 min (!) and diagnostic yields of over 65%, (!) doubling the global standard.
Identifying the causal genetic mutation in such cases, presented in neonatal and pediatric intensive care units (NICU and PICU), is crucial for applying the right treatment which can be lifesaving. Increasing the accuracy (diagnostic yield) and decreasing the time required for the genetic analysis (turn-around-time) are key to the work of the geneticists in these cases. Today we are working with more than 20 children hospitals, in Italy, China, Hong Kong, Israel, and others.